Ferrisilicate composition and method for treating insulin deficiency
AssigneeImam Abdulrahman Bin Faisal University
InventorsB. Rabindran JERMY, Vijaya RAVINAYAGAM, Mohammed SALAHUDDIN
Life of this patent
Estimating the term…
Abstract
A method of delivering insulin, including: orally administering to a subject a composition containing a ferrisilicate material, polyethylene glycol, and insulin. The insulin at least partially penetrates pores of the ferrisilicate material to form a ferrisilicate insulin composite and the polyethylene glycol, at least partially enfolds the ferrisilicate insulin composite to form the composition. The composition has an insulin release rate of 10-50% after 100-500 hours following oral administration.
Claims19
A method of administering insulin, comprising:
- orally administering to a subject a composition comprising,
- a ferrisilicate material having one or more pores, the one or more pores having an average pore size of from 2 nm to 5 nm;
- polyethylene glycol;
- and
- insulin;
- wherein the composition is administered in the form of granules, a suspension or tablet,
- wherein the insulin at least partially penetrates the pores of the ferrisilicate material to form a ferrisilicate insulin composite,
- wherein the polyethylene glycol, at least partially enfolds the ferrisilicate insulin composite, and
- wherein the composition has a cumulative insulin release of about 40% after 500 hours following oral administration.
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.